Member Info for Mafuta

Again another positive RNS ... Looks like the company is trying to get a positive message out ... LH&K Mafuta

Hey Maidit ... Don't think for one minute everyone dislikes your posts ... All opinions add to the mix so don't you worry ... LH&K Mafuta

After being weeks in the doldrums we seem to see some good upwards movement ... I get the sense that the market is expecting some positive news very soon ... Once the deal on Sierra is settled we can look forward to some news on 737 but not holding my breath on that one they may hold their cards close to their chest ... CTA news will drop soon and that will no doubt help ... Still a solid hold for me ... I'm in no hurry ... LH&K Mafuta

Has anyone noticed the lack of the commoners? ... are they all watching the tennis?

A positive RNS ... such a pity it wasn't released soon after the non conclusive test results. Hopefully the market will react positively ... LH&K Mafuta

Red dot searching has become a ritual for many ... Including me and not only for SAR ... But the dots will come when their time is due ... I expect some action once the dust settles on the Sierra deal ... Not long to wait... LH&K Mafuta

We're doomed ... Doomed I tell ye ... Oh do dry up Fraser ...

Good elcap ... I'm still a bit under water with this one ... but I'm in no hurry

thanks barnsbury ... sorry gin my bad maths

It doesn't seem to have adversely affected the SP though. The shares will be admitted to market on 21st June.

LH&K Mafuta

Gin ... Someone (trx haven't mentioned who) has exercised their right exercise their option to subscribe for 2,717,391 new ordinary shares in the Company at an exercise price of 0.1 pence per Ordinary Share.
It will result in a small dilution of approximately 0.3% not much really it will be interesting to find out who has exercised their option though ...
LH &K Mafuta

Hi elcap

Or it could be someone posted one of the following shalt nots?

b. post any confidential or price sensitive information or that is not public knowledge.

d. post any private communication, or part thereof, from any other person, including from a member of the board of directors of a listed company.

LH&K Mafuta

Highlights:
· Agreement signed with Behnke Group, USA, to promote, identify and facilitate partnerships for Cizzle Biotechnology with healthcare providers and businesses in the USA.
· The Behnke Group to establish targeted lead generation campaigns to aid formulating marketing and branding strategies and work with their network of USA based health systems, clinical diagnostic and pharmaceutical companies.
· The Behnke Group will work together with CorePath, a Clinical Laboratory Improvement Amendments ("CLIA") and College of American Pathologists ("CAP") accredited laboratory, to assist the Company.

Laz ... poodles and lap dogs ... LH&K Mafuta

Now .... Why would they be reminding people of that ... It's old news really ... Or are they waving a rag at a bull?

Sareum Holdings PLC - Cambridge, England-based drug developer for cancer and autoimmune diseases - Notes agreement for Sierra Oncology Inc to be acquired by GlaxoSmithKline PLC. Sierra is the license holder for SRA737, a treatment discovered and developed by Sareum before the license was sold to Sierra. Sierra has several potential clinical trials in the pipeline for SRA737 as a combination treatment for haematologic and solid tumour indications. According to an amended USD299 million licensing deal for the drug, Sareum still has a 28% share of future milestone payments as well as royalties on future sales. "The dosing of the first patient with SRA737 in any new clinical trial would result in a USD2.0m payment from Sierra, with 28% of this due to Sareum," the company explains.

Why else would the chuckle brothers be posting? ... LH&K Mafuta

Happy birthday 1Hypolita

Aber ... It is a bit frustrating but guess we will find out soon ... hopefully ... LH&K Mafuta